Emerging Technologies for Diabetes Care
New therapies, monitoring, and revolutionary enabling technologies applied to healthcare represent an historic opportunity to improve the lives of people with diabetes. These advances enable more meaningful monitoring of blood glucose values with the facilitation of more optimal insulin dosing and delivery. Newer insulins and delivery systems are in development that seek to mitigate both hyperglycemia and hypoglycemia and increase time in range. Information systems now exist that may be leveraged to merge data from previously discrete systems into new models of connected care. This review highlights important developments that serve to increase effectiveness while reducing the burden of diabetes care in the near future.
Download PDF Brochure of Study Here
Diabetes is a complex, chronic condition estimated in 2014 by the World Health Organization to affect 422 million people globally. Despite significant therapeutic advancements, a person with diabetes routinely experiences physiological, cognitive, pragmatic, and psychological burdens. To achieve and maintain optimal glycemic control, those who require insulin generally must engage in time-consuming behaviors such as frequent glucose monitoring (GM) and quantifying (“counting”) carbohydrate intake, while also taking into consideration variables such as noncarbohydrate food content, exercise, illness, menstruation, stress, and other life events to adjust their medication doses. These ongoing efforts are undertaken while also attempting to avoid hypo- and hyperglycemia and lead normal lives. A person must not only have access to the right therapy (ideally individualized), but also be engaged in and adherent to a treatment plan that requires lifestyle changes to manage this complex disease. Many fail to achieve their glycemic goals due to multiple factors, including delays in intensification of treatment regimens (on the part of the patient as well as the clinician), resistance to changes in lifestyle, lack of patient education resources, inadequate treatment regimens, and poor adherence to treatment.
This review highlights emerging technologies in the fields of insulins, GM, medication delivery, data management, and decision analysis. It will additionally explore the importance of connected care and the changing roles required for the person with diabetes and the clinician who strives to provide their care.
Reference
- theinsightpartners.com
- liebertpub.com